Join Dr. Pamela Soliman, Professor and Deputy Chair in the Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery at MD Anderson Cancer Center, for an expert update on uterine cancer from the 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer.
Dr. Soliman will highlight key research presented at the conference, review emerging treatment strategies and clinical trials, and discuss what these developments mean for patients impacted by uterine cancer. The session will conclude with a live Q&A to address participant questions.
Key Takeaways:
- Multiple ongoing clinical trials that are going to impact clinical practice
- With novel therapies we have to learn to manage drugs with new side effect profiles
- Sequencing of therapy is going to be our next priority as more drugs become commercially available
- Long term follow up is important to confirm early findings and help with counselling patients
- Novel ways to support patients through treatment can also havea an impact on outcomes